1. Home
  2. Analysis

Cachexia and drugs of ingredients of tipranavir (a real world drug study)


Summary:

Cachexia is found among people who take drugs with ingredients of tipranavir, especially for people who are male, 40-49 old , have been taking the drugs for 2 - 5 years. This phase IV clinical study is created by eHealthMe based on reports of 1,634 people who have side effects when taking drugs with ingredients of tipranavir from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Aptivus.

On Jun, 19, 2026

1,634 people reported to have side effects when taking drugs with ingredients of tipranavir.
Among them, 35 people (2.14%) have Cachexia

What is Cachexia?

Cachexia (loss of weight) is found to be associated with 664 drugs and 1,201 conditions by eHealthMe. Check the latest studies of Cachexia.

Number of reports submitted per year:

Could drugs with ingredients of tipranavir cause Cachexia?

Time on drugs with ingredients of tipranavir when people have Cachexia *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 50 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 50 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Cachexia when taking drugs with ingredients of tipranavir *:

  • female: 28.57 %
  • male: 71.43 %

Age of people who have Cachexia when taking drugs with ingredients of tipranavir *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 21.43 %
  • 30-39: 10.71 %
  • 40-49: 57.14 %
  • 50-59: 7.14 %
  • 60+: 3.5700000000000003 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Hiv Infection: 28 people, 80.00%
  2. Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 9 people, 25.71%
  3. Stress And Anxiety: 1 person, 2.86%
  4. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 2.86%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Ritonavir: 24 people, 68.57%
  2. Truvada: 22 people, 62.86%
  3. Lamivudine: 6 people, 17.14%
  4. Stavudine: 6 people, 17.14%
  5. Prezista: 3 people, 8.57%
  6. Epivir: 3 people, 8.57%
  7. Norvir: 3 people, 8.57%
  8. Videx Ec: 3 people, 8.57%
  9. Bactrim: 3 people, 8.57%
  10. Viread: 3 people, 8.57%

Other side effects people have besides Cachexia *:

You may use this to check any potential undetected side effects.

  1. Diarrhea: 21 people, 60.00%
  2. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 19 people, 54.29%
  3. Blood Bilirubin Unconjugated Increased: 16 people, 45.71%
  4. Bilirubin Conjugated Increased: 14 people, 40.00%
  5. Gastritis (inflammation of stomach): 6 people, 17.14%
  6. Fever: 3 people, 8.57%
  7. Nausea (feeling of having an urge to vomit): 3 people, 8.57%
  8. Upper Gastrointestinal Haemorrhage (upper gastrointestinal bleeding): 2 people, 5.71%
  9. Stress And Anxiety: 2 people, 5.71%
  10. Haematochezia (passage of stools containing blood): 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of tipranavir, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on tipranavir. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.